L-Nutra Secures $36.5M to Revolutionize Longevity Through Nutrition Science
L-Nutra Secures $36.5M to Revolutionize Longevity Through Nutrition Science
L-Nutra Secures $36.5M to Revolutionize Longevity Through Nutrition Science
L-Nutra, a Los Angeles-based nutrition technology firm, has secured an extra $36.5 million in its latest funding round. The investment pushes the company's Series D total to $83.5 million, with Mubadala leading the effort. Specialising in longevity and medical nutrition, the company claims to be nearing breakthroughs in human healthspan improvement.
The new funding follows L-Nutra's completion of two fresh clinical trials since 2024. These studies focused on its fasting-mimicking diet, exploring benefits for cancer patients and metabolic health. To date, the company has carried out 47 trials and holds 137 patents related to chronic disease remission and longevity.
Joseph Antoun, the firm's chairman and CEO, stated that L-Nutra now stands 'on the cusp of enhancing human healthspan.' The company's work centres on nutrition-based therapies designed to extend healthy lifespans and manage long-term illnesses.
Part of the investment will support a planned joint operation with Mubadala in Abu Dhabi. This facility aims to produce medical nutrition and longevity-focused products for markets across the Middle East and North Africa.
The latest funding boosts L-Nutra's capacity to expand its research and production. With clinical trials ongoing and a new regional hub in development, the company is set to scale its nutrition-based therapies. The partnership with Mubadala also signals growing interest in medical nutrition solutions for global health challenges.
US urges airlines to offer healthier free snacks on long-haul flights
Flying hungry? The US wants airlines to ditch processed snacks and serve fruit and veggies—for free. But will carriers listen?
Algae-based foods may contain dangerous iodine levels without warnings
Your healthy algae snack could be a silent threat. Researchers expose alarming iodine levels in everyday foods—and why labels fail to protect you.
RHÖN-KLINIKUM AG reports record growth and €1.7B revenue in 2025
A year of breakthroughs: nearly a million patients served, cutting-edge tech deployed, and dividends on the horizon. What's next for this healthcare giant?
Kazakhstan bans junk food and sugary drinks in schools by 2025
A bold move to protect children's health—or just the first step? Kazakhstan cracks down on junk food in schools while questions linger about unregulated sales nearby.